4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one

C24H17ClF6N2O2 — CID 15896160

IUPAC4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one
SMILESO=C1c2c(-c3ccccc3)cc(CCl)nc2OCCN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1
InChIInChI=1S/C24H17ClF6N2O2/c25-12-18-11-19(15-4-2-1-3-5-15)20-21(32-18)35-7-6-33(22(20)34)13-14-8-16(23(26,27)28)10-17(9-14)24(29,30)31/h1-5,8-11H,6-7,12-13H2
InChIKeyYKDUDIWXQXNARS-UHFFFAOYSA-N
MW514.85 g/mol
LogP6.56
Rot. Bonds4

About 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one

4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one (PubChem CID 15896160) has the molecular formula C24H17ClF6N2O2 and a molecular weight of 514.85 g/mol. Its IUPAC name is 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one.

Molecular Properties

Compound Name4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one
PubChem CID15896160
Molecular FormulaC24H17ClF6N2O2
Molecular Weight514.85 g/mol
Exact Mass514.09
IUPAC Name4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one
SMILESO=C1c2c(-c3ccccc3)cc(CCl)nc2OCCN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1
InChIInChI=1S/C24H17ClF6N2O2/c25-12-18-11-19(15-4-2-1-3-5-15)20-21(32-18)35-7-6-33(22(20)34)13-14-8-16(23(26,27)28)10-17(9-14)24(29,30)31/h1-5,8-11H,6-7,12-13H2
InChIKeyYKDUDIWXQXNARS-UHFFFAOYSA-N
XLogP6.56
TPSA42.43 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500514.85
LogP ≤ 56.56
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one?
The IUPAC name of 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one (CID 15896160) is 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one.
What is the SMILES notation for 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one?
The canonical SMILES for 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one is O=C1c2c(-c3ccccc3)cc(CCl)nc2OCCN1Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1.
What is the InChIKey of 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one?
The InChIKey is YKDUDIWXQXNARS-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H17ClF6N2O2/c25-12-18-11-19(15-4-2-1-3-5-15)20-21(32-18)35-7-6-33(22(20)34)13-14-8-16(23(26,27)28)10-17(9-14)24(29,30)31/h1-5,8-11H,6-7,12-13H2.
What are the key properties of 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one?
4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one has a molecular weight of 514.85 g/mol, XLogP of 6.56, 4 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[3,5-bis(trifluoromethyl)phenyl]methyl]-8-(chloromethyl)-6-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepin-5-one is sourced from PubChem (CID 15896160), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).